重新定义并情境化机器人辅助根治性前列腺切除术的医院量-结局关系:对集中化医疗的启示
该研究基于2009至2011年美国全国住院患者样本中140,671例机器人辅助根治性前列腺切除术,分析医院手术量与非围手术期结局及总费用的关系,发现手术量增至约每年100例前结局持续改善,之后改善有限,且2011年70%医院平均每周不超过1例,承担28%手术。
要点
- 医院机器人辅助根治性前列腺切除术量增至约每年100例前,围手术期结局改善,之后改善有限。
- 2011年70%医院平均每周≤1例机器人辅助根治性前列腺切除术,承担28%的手术。
- 最高四分位医院较低四分位医院的围手术期并发症、输血、延长住院率和费用均更低。
核心结论
- 医院机器人辅助根治性前列腺切除术量增加与围手术期结局改善相关,直至约每年100例,之后改善似乎有限。
- 相当比例机器人辅助根治性前列腺切除术在低手术量医院开展。
研究设计与样本
- 研究识别2009至2011年美国全国住院患者样本(NIS)中140,671例接受机器人辅助根治性前列腺切除术的男性。
- 采用多变量逻辑回归和广义线性模型评估医院手术量与围手术期结局及总住院费用的关联。
主要发现
- 最高四分位医院较低四分位医院:术中并发症0.6% vs 1.4%,术后并发症4.8% vs 13.9%,围手术期输血1.5% vs 4.0%,延长住院4.3% vs 13.8%,平均总住院费用$12,647 vs $15,394,所有趋势P<0.001。
- 2011年70%医院平均每周≤1例机器人辅助根治性前列腺切除术,承担28%的手术。
- 将医院手术量作为非线性连续变量建模,医院手术量增加与每个围手术期终点的改善独立相关,直至约每年100例机器人辅助根治性前列腺切除术,之后似乎仅有边缘改善。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Robot-assisted radical prostatectomy has undergone rapid dissemination driven in part by market forces to become the most frequently used surgical approach in the management of prostate cancer. Accordingly, a critical analysis of its volume-outcome relationship has important health policy implications. Therefore, we evaluated the association of hospital robot-assisted radical prostatectomy volume with perioperative outcomes, and examined the distribution of hospital procedure volume to contextualize the volume-outcome relationship. MATERIALS AND METHODS: We identified 140,671 men who underwent robot-assisted radical prostatectomy from 2009 to 2011 in NIS (Nationwide Inpatient Sample). The associations of hospital volume with perioperative outcomes and total hospital costs were evaluated using multivariable logistic regression and generalized linear models. RESULTS: In 2011, 70% of hospitals averaged 1 robot-assisted radical prostatectomy per week or less, accounting for 28% of surgeries. Compared to patients treated at the lowest quartile hospitals, those treated at the highest quartile hospitals had significantly lower rates of intraoperative complications (0.6% vs 1.4%), postoperative complications (4.8% vs 13.9%), perioperative blood transfusion (1.5% vs 4.0%), prolonged hospitalization (4.3% vs 13.8%) and mean total hospital costs ($12,647 vs $15,394, all ptrend <0.001). When modeled as a nonlinear continuous variable, increasing hospital volume was independently associated with improved rates of each perioperative end point up to approximately 100 robot-assisted radical prostatectomies per year, beyond which there appeared to be marginal improvement. CONCLUSIONS: Increasing hospital robot-assisted radical prostatectomy volume was associated with improved perioperative outcomes up to approximately 100 surgeries per year, beyond which there appeared to be marginal improvement. A substantial proportion of these procedures is performed at low volume hospitals.
引用
- Gershman B, Meier SK, Jeffery MM, et al. Redefining and Contextualizing the Hospital Volume-Outcome Relationship for Robot-Assisted Radical Prostatectomy: Implications for Centralization of Care. J Urol. 2017. PMID: 28153509. doi:10.1016/j.juro.2017.01.067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。